243 related articles for article (PubMed ID: 35842684)
21. Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
Xu X; Wang W; Lin L; Chen P
Tissue Cell; 2020 Oct; 66():101382. PubMed ID: 32933722
[TBL] [Abstract][Full Text] [Related]
22. Reduction of Emphysema Severity by Human Umbilical Cord-Derived Mesenchymal Stem Cells in Mice.
Laiman V; Lee YL; Hou YW; Fang YT; Chen YY; Lo YC; Heriyanto DS; Lan SC; Chen CL; Chen XY; Lee KY; Chang JH; Chuang HC
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012176
[TBL] [Abstract][Full Text] [Related]
23. Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury.
Fang TC; Pang CY; Chiu SC; Ding DC; Tsai RK
PLoS One; 2012; 7(9):e46504. PubMed ID: 23029541
[TBL] [Abstract][Full Text] [Related]
24. What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
Xie Q; Liu R; Jiang J; Peng J; Yang C; Zhang W; Wang S; Song J
Stem Cell Res Ther; 2020 Dec; 11(1):519. PubMed ID: 33261658
[TBL] [Abstract][Full Text] [Related]
25. Human umbilical cord mesenchymal stem cells promoted tumor cell growth associated with increased interleukin-18 in hepatocellular carcinoma.
Yang Y; Li S; Peng Q; Guo Y; Gao Y; Gong Y; Lu J; Zhang Y; Shi X
Mol Biol Rep; 2024 Jun; 51(1):762. PubMed ID: 38874690
[TBL] [Abstract][Full Text] [Related]
26. Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial.
Meng F; Xu R; Wang S; Xu Z; Zhang C; Li Y; Yang T; Shi L; Fu J; Jiang T; Huang L; Zhao P; Yuan X; Fan X; Zhang JY; Song J; Zhang D; Jiao Y; Liu L; Zhou C; Maeurer M; Zumla A; Shi M; Wang FS
Signal Transduct Target Ther; 2020 Aug; 5(1):172. PubMed ID: 32855385
[TBL] [Abstract][Full Text] [Related]
27. Human umbilical cord mesenchymal stem cells combined with pirfenidone upregulates the expression of RGS2 in the pulmonary fibrosis in mice.
Wu X; Gou H; Zhou O; Qiu H; Liu H; Fu Z; Chen L
Respir Res; 2022 Oct; 23(1):270. PubMed ID: 36182915
[TBL] [Abstract][Full Text] [Related]
28. Effect of human umbilical cord-derived mesenchymal stem cells on murine model of bronchiolitis obliterans like injury.
Lin J; Deng H; Zhang Y; Zou L; Fu Z; Dai J
Pediatr Pulmonol; 2021 Jan; 56(1):129-137. PubMed ID: 33085211
[TBL] [Abstract][Full Text] [Related]
29. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression.
Liao Y; Fu Z; Huang Y; Wu S; Wang Z; Ye S; Zeng W; Zeng G; Li D; Yang Y; Pei K; Yang J; Hu Z; Liang X; Hu J; Liu M; Jin J; Cai C
Cell Death Dis; 2023 Jan; 14(1):66. PubMed ID: 36707501
[TBL] [Abstract][Full Text] [Related]
31. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling.
He Y; Guo X; Lan T; Xia J; Wang J; Li B; Peng C; Chen Y; Hu X; Meng Z
Stem Cell Res Ther; 2021 Jul; 12(1):396. PubMed ID: 34256837
[TBL] [Abstract][Full Text] [Related]
32. Bio-distribution and toxicity potential of human umbilical cord mesenchymal stem cells in cynomolgus monkeys.
Huang Y; Hao X; Lin Z; Li L; Jiang H; Zhang H; Geng X; Zhu H; Wen H
Sci Rep; 2024 May; 14(1):12251. PubMed ID: 38806615
[TBL] [Abstract][Full Text] [Related]
33. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.
Shi L; Huang H; Lu X; Yan X; Jiang X; Xu R; Wang S; Zhang C; Yuan X; Xu Z; Huang L; Fu JL; Li Y; Zhang Y; Yao WQ; Liu T; Song J; Sun L; Yang F; Zhang X; Zhang B; Shi M; Meng F; Song Y; Yu Y; Wen J; Li Q; Mao Q; Maeurer M; Zumla A; Yao C; Xie WF; Wang FS
Signal Transduct Target Ther; 2021 Feb; 6(1):58. PubMed ID: 33568628
[TBL] [Abstract][Full Text] [Related]
34. A robust and standardized method to isolate and expand mesenchymal stromal cells from human umbilical cord.
Todtenhaupt P; Franken LA; Groene SG; van Hoolwerff M; van der Meeren LE; van Klink JMM; Roest AAW; de Bruin C; Ramos YFM; Haak MC; Lopriore E; Heijmans BT; van Pel M
Cytotherapy; 2023 Oct; 25(10):1057-1068. PubMed ID: 37516948
[TBL] [Abstract][Full Text] [Related]
35. Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation.
Zhang M; Zhao Y; Wang L; Zheng Y; Yu H; Dong X; He W; Yin Z; Wang Z
Cell Tissue Bank; 2022 Dec; 23(4):739-752. PubMed ID: 35066739
[TBL] [Abstract][Full Text] [Related]
36. Quantification of the CM-Dil-labeled human umbilical cord mesenchymal stem cells migrated to the dual injured uterus in SD rat.
Zheng JH; Zhang JK; Kong DS; Song YB; Zhao SD; Qi WB; Li YN; Zhang ML; Huang XH
Stem Cell Res Ther; 2020 Jul; 11(1):280. PubMed ID: 32660551
[TBL] [Abstract][Full Text] [Related]
37. Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice.
Lv X; Guan C; Li Y; Su X; Zhang L; Wang X; Xia HF; Ma X
J Ovarian Res; 2021 Sep; 14(1):119. PubMed ID: 34526090
[TBL] [Abstract][Full Text] [Related]
38. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats.
Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH
Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
